Daniel S Lupu (Daniel Lupu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Extracorporeal Membrane Oxygenation

Community Acquired Pneumonia

End Stage Renal Disease

Electronic Health Record

Top Venues

PharmacoEconomics

JCO clinical cancer informatics

Drugs - real world outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Thales C Nepomuceno, Paulo Lyra, Jianbin Zhu, Fanchao Yi, Rachael H Martin, Daniel S Lupu, Luke Peterson, Lauren C Peres, Anna B Berry, Edwin S Iversen, Fergus J Couch, Qianxing Mo, Alvaro N A Monteiro
Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO clinical cancer informatics 8 (2024)
Thales C Nepomuceno, Paulo Lyra, Jianbin Zhu, Fanchao Yi, Rachael H Martin, Daniel S Lupu, Luke Peterson, Lauren C Peres, Anna B Berry, Edwin S Iversen, Fergus J Couch, Qianxing Mo, Alvaro N A Monteiro
Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO clinical cancer informatics 8 (2024)
Thales C Nepomuceno, Paulo Lyra, Jianbin Zhu, Fanchao Yi, Rachael H Martin, Daniel S Lupu, Luke Peterson, Lauren C Peres, Anna B Berry, Edwin S Iversen, Fergus J Couch, Qianxing Mo, Alvaro N A Monteiro
Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO clinical cancer informatics 8 (2024)
Thales C Nepomuceno, Paulo Lyra, Jianbin Zhu, Fanchao Yi, Rachael H Martin, Daniel S Lupu, Luke Peterson, Lauren C Peres, Anna B Berry, Edwin S Iversen, Fergus J Couch, Qianxing Mo, Alvaro N A Monteiro
Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO clinical cancer informatics 8 (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics (2024)
Gregory M Miller, J Austin Ellis, Rangaprasad Sarangarajan, Amay Parikh, Leonardo O Rodrigues, Can Bruce, Nischal Mahaveer Chand, Steven R Smith, Kris Richardson, Raymond Vazquez, Michael A Kiebish, Chandran Haneesh, Elder Granger, Judy Holtz, Jacob Hinkle, Niven R Narain, Bret Goodpaster, Jeremy C Smith, Daniel S Lupu
Hypothesis-Agnostic Network-Based Analysis of Real-World Data Suggests Ondansetron is Associated with Lower COVID-19 Any Cause Mortality. Drugs - real world outcomes 9 (3) (2022)